InspireMD, Inc. — Director's Dealing 2021

May 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2021-05-10

Reporting Person: Arnold Kathryn (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-10	Common Stock	A	10536	—	Acquired	10536	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-10	Option to Purchase Common Stock	$4.74	A	3512	Acquired	2031-05-10	Common Stock (3512)	Direct

Footnotes

F1: The shares of common stock reported in this row represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 10, 2022, May 10, 2023 and May 10, 2024, subject to the Reporting Person's continued service.

F2: The options reported in this row vest and become exercisable in three equal installments, with 1/3 vesting on each of May 10, 2022, May 10, 2023 and May 10, 2024, subject to the Reporting Person's continued service.